Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 12 | 2021 | 272 | 3.150 |
Why?
|
| NF-E2-Related Factor 2 | 8 | 2022 | 110 | 2.110 |
Why?
|
| Mitochondria | 7 | 2019 | 643 | 1.350 |
Why?
|
| Dopaminergic Neurons | 3 | 2018 | 46 | 1.120 |
Why?
|
| MPTP Poisoning | 6 | 2012 | 10 | 1.060 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 7 | 2021 | 22 | 0.920 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2022 | 19 | 0.850 |
Why?
|
| Neuroprotection | 2 | 2021 | 28 | 0.820 |
Why?
|
| Parkinsonian Disorders | 2 | 2016 | 43 | 0.800 |
Why?
|
| Oxidative Stress | 8 | 2022 | 718 | 0.770 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 102 | 0.690 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 17 | 0.620 |
Why?
|
| Neuroprotective Agents | 4 | 2018 | 317 | 0.610 |
Why?
|
| MicroRNAs | 2 | 2021 | 447 | 0.610 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 2550 | 0.610 |
Why?
|
| Mice, Knockout | 11 | 2021 | 1692 | 0.600 |
Why?
|
| Fumarates | 1 | 2016 | 28 | 0.540 |
Why?
|
| alpha-Synuclein | 3 | 2011 | 28 | 0.540 |
Why?
|
| Animals | 23 | 2022 | 20881 | 0.450 |
Why?
|
| Mice | 17 | 2022 | 8474 | 0.450 |
Why?
|
| Histones | 1 | 2013 | 111 | 0.430 |
Why?
|
| Signal Transduction | 4 | 2019 | 2689 | 0.410 |
Why?
|
| Triterpenes | 1 | 2012 | 40 | 0.410 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 163 | 0.400 |
Why?
|
| Antioxidant Response Elements | 3 | 2021 | 10 | 0.400 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2007 | 89 | 0.390 |
Why?
|
| Cyclophilins | 1 | 2011 | 6 | 0.390 |
Why?
|
| beta-Synuclein | 1 | 2011 | 1 | 0.380 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2011 | 41 | 0.380 |
Why?
|
| Neurons | 4 | 2021 | 881 | 0.380 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 25 | 0.380 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 16 | 0.380 |
Why?
|
| Substantia Nigra | 3 | 2011 | 102 | 0.380 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 562 | 0.360 |
Why?
|
| Dopamine | 1 | 2012 | 474 | 0.350 |
Why?
|
| Catecholamines | 1 | 2007 | 73 | 0.280 |
Why?
|
| Tauopathies | 2 | 2018 | 6 | 0.280 |
Why?
|
| Locus Coeruleus | 1 | 2007 | 55 | 0.280 |
Why?
|
| Humans | 17 | 2021 | 68618 | 0.230 |
Why?
|
| Rats | 4 | 2021 | 5300 | 0.230 |
Why?
|
| Heme Oxygenase-1 | 1 | 2022 | 40 | 0.210 |
Why?
|
| Ginsenosides | 1 | 2022 | 4 | 0.200 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2022 | 15 | 0.200 |
Why?
|
| Ependymoglial Cells | 2 | 2019 | 7 | 0.200 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 137 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 2791 | 0.180 |
Why?
|
| Central Nervous System | 1 | 2021 | 107 | 0.180 |
Why?
|
| Hyperhomocysteinemia | 1 | 2019 | 15 | 0.170 |
Why?
|
| Sepsis | 1 | 2022 | 233 | 0.170 |
Why?
|
| Neurotoxins | 2 | 2011 | 30 | 0.170 |
Why?
|
| Cell Survival | 3 | 2018 | 901 | 0.170 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 475 | 0.160 |
Why?
|
| Thiamine | 1 | 2018 | 11 | 0.160 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 13 | 0.160 |
Why?
|
| Retinal Ganglion Cells | 1 | 2019 | 72 | 0.160 |
Why?
|
| Radiation-Protective Agents | 1 | 2018 | 16 | 0.160 |
Why?
|
| Homocysteine | 1 | 2018 | 28 | 0.160 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2018 | 17 | 0.150 |
Why?
|
| Prolyl Hydroxylases | 1 | 2017 | 2 | 0.150 |
Why?
|
| Ascorbic Acid | 1 | 2017 | 45 | 0.150 |
Why?
|
| tau Proteins | 2 | 2018 | 61 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2022 | 617 | 0.150 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2018 | 46 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1553 | 0.150 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 81 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2013 | 786 | 0.140 |
Why?
|
| Maleates | 1 | 2016 | 7 | 0.140 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 2 | 2018 | 4 | 0.140 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 100 | 0.140 |
Why?
|
| Isoflurophate | 1 | 2015 | 9 | 0.130 |
Why?
|
| Organelles | 1 | 2015 | 18 | 0.130 |
Why?
|
| Tyrosine | 1 | 2016 | 196 | 0.130 |
Why?
|
| Antigens, CD | 1 | 2016 | 230 | 0.130 |
Why?
|
| Axons | 1 | 2015 | 139 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2015 | 525 | 0.120 |
Why?
|
| Methylene Blue | 1 | 2014 | 16 | 0.120 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 11 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1293 | 0.110 |
Why?
|
| Dopamine Agents | 2 | 2011 | 56 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 415 | 0.110 |
Why?
|
| Quality of Life | 1 | 2021 | 1515 | 0.100 |
Why?
|
| Cell Death | 2 | 2011 | 329 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1745 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4848 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2013 | 193 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2012 | 411 | 0.100 |
Why?
|
| Basal Ganglia | 1 | 2011 | 45 | 0.100 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2011 | 71 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2004 | 382 | 0.090 |
Why?
|
| Microglia | 1 | 2011 | 143 | 0.090 |
Why?
|
| Antioxidants | 2 | 2022 | 304 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2011 | 791 | 0.080 |
Why?
|
| Astrocytes | 1 | 2011 | 270 | 0.080 |
Why?
|
| Female | 6 | 2021 | 38074 | 0.080 |
Why?
|
| Peroxidases | 1 | 2007 | 28 | 0.070 |
Why?
|
| Peroxidase | 1 | 2007 | 40 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 35 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 134 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 929 | 0.070 |
Why?
|
| Benzylamines | 1 | 2007 | 28 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2007 | 39 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 194 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1033 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2007 | 235 | 0.070 |
Why?
|
| Lewy Bodies | 1 | 2006 | 7 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2007 | 276 | 0.070 |
Why?
|
| Mutation | 2 | 2008 | 1213 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2007 | 156 | 0.070 |
Why?
|
| Male | 4 | 2021 | 37321 | 0.070 |
Why?
|
| Aged | 1 | 2021 | 14862 | 0.070 |
Why?
|
| Apoptosis | 1 | 2011 | 1641 | 0.060 |
Why?
|
| Brain | 3 | 2018 | 2176 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2004 | 74 | 0.060 |
Why?
|
| Risk Factors | 1 | 2013 | 5731 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2022 | 11 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2673 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2022 | 231 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2019 | 147 | 0.040 |
Why?
|
| Glycolysis | 1 | 2019 | 79 | 0.040 |
Why?
|
| Electroretinography | 1 | 2019 | 122 | 0.040 |
Why?
|
| Cell Count | 1 | 2019 | 248 | 0.040 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2018 | 10 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 143 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2018 | 6 | 0.040 |
Why?
|
| Limonins | 1 | 2018 | 10 | 0.040 |
Why?
|
| Prolyl-Hydroxylase Inhibitors | 1 | 2017 | 2 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2017 | 169 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 196 | 0.040 |
Why?
|
| Retina | 1 | 2019 | 252 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 191 | 0.040 |
Why?
|
| Glutathione | 1 | 2018 | 343 | 0.030 |
Why?
|
| Cell Line | 2 | 2014 | 1752 | 0.030 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2015 | 58 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 682 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 210 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1027 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1593 | 0.030 |
Why?
|
| Nitric Oxide Donors | 2 | 2004 | 54 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 1851 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 2 | 2004 | 163 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2014 | 470 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 2083 | 0.020 |
Why?
|
| Aging | 2 | 2007 | 911 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1266 | 0.020 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2334 | 0.020 |
Why?
|
| Tuberous Sclerosis | 1 | 2008 | 13 | 0.020 |
Why?
|
| Threonine | 1 | 2008 | 47 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2007 | 39 | 0.020 |
Why?
|
| Peroxiredoxins | 1 | 2007 | 34 | 0.020 |
Why?
|
| Exons | 1 | 2007 | 122 | 0.020 |
Why?
|
| Cysteine | 1 | 2007 | 112 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 159 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 108 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 149 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 168 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 284 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 331 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 567 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2006 | 282 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 1200 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 1174 | 0.020 |
Why?
|
| Synucleins | 1 | 2004 | 1 | 0.010 |
Why?
|
| Lewy Body Disease | 1 | 2004 | 9 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 73 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2004 | 99 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 216 | 0.010 |
Why?
|
| Citric Acid | 1 | 2002 | 16 | 0.010 |
Why?
|
| Ferrous Compounds | 1 | 2002 | 18 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 782 | 0.010 |
Why?
|
| Free Radicals | 1 | 2002 | 65 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 290 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 742 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 201 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 597 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 565 | 0.010 |
Why?
|